Randomized phase II trial of neoadjuvant combined modality therapy for locally advanced rectal cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 27 Feb 2020 Biomarkers information updated
- 15 Mar 2012 Results published in the International Journal of Radiation Oncology, Biology, Physics.
- 10 Jun 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.